Schering-Plough selects metabolic compound for development
Schering-Plough has selected a compound identified in its ongoing collaboration with Pharmacopeia for preclinical development. The compound will be examined ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.